The U.S. Food and Drug Administration (FDA) announced on Wednesday (October 29) a plan to streamline the approval process for ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

The Food and Drug Administration said it will be taking steps to speed up the approval process for developing generic biological drugs, an effort aimed at increasing cheaper competition among ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative ...

The FDA said it proposed significant changes to simplify biosimilarity studies and reduce what it described as unnecessary ...

There are three obstacles to faster development and deployment of non-addictive pain treatments. They are the business ...

The US Food and Drug Administration (FDA) has announced major steps to make it faster and less costly to develop biosimilar ...

The United States has said it will speed up approval for some generic drugs. The development comes weeks after it was ...

As drug prices continue to rise and the affordability of medicines for patients remains out of reach, finding new and creative solutions that address affordability, while also rewarding innovation, is ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio-Antibiotic is primarily used for ...